SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-021270
Filing Date
2023-02-14
Accepted
2023-02-14 13:50:29
Documents
2
Group Members
JOHAN WEDELL-WEDELLSBORG

Document Format Files

Seq Description Document Type Size
1 SC 13G tm236789d1_sc13g.htm SC 13G 53493
2 EXHIBIT 1 tm236789d1_ex99-1.htm EX-99.1 5462
  Complete submission text file 0001104659-23-021270.txt   60465
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Subject) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90649 | Film No.: 23626706
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960 45-45-17-77-77
WG Biotech ApS (Filed by) CIK: 0001753193 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13G